“GervanoRA’s Clinical trials report “Herpesviridae Infections: Comprehensive Global Clinical Trials Analytics H2 2018” provides an in-depth analysis of the overall clinical trials for Herpesviridae Infections. The report caters information related to the global clinical trials with respect to their Phase, Trial Status, Intervention, Trial type and Endpoint status. Our report exclusively focuses on providing insights and competitive opportunities based on Biomarker or target receptor, Drug Class and Mechanism of Action to aid in understanding the upcoming newer research trends in the field of Herpesviridae Infections drug discovery. The report offers coverage of Herpesviridae Infections clinical trials by region and average enrollment by country. Country based analytics are provided according to the Top 5 Clinical trial sites globally and the emerging countries supporting with a platform to conduct clinical trials effectively. Analytics are also provided for the subjects enrolled over a period of time, Herpesviridae Infections clinical trials by sponsor type and the top companies involved in the R&D of Herpesviridae Infections drug development. In addition, the report gives a brief overview on the major drugs undergoing trials and the recent advancements observed in the Herpesviridae Infections clinical trials.